Daily Wrap

What a day of surprises to end the month. The session started modestly lower after Moderna’s (MRNA -4.4%) CEO told the Financial Times that he expects current vaccines to be materially less effective against the Omicron variant. Notwithstanding similar comments he made to CNBC yesterday, and reports suggesting that vaccines are likely to protect against severe disease, the uncertainty upset…